NPI: 1447383831 · GREENVILLE, SC 29615 · 152W00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,826 | $222K |
| 2019 | 6,085 | $326K |
| 2020 | 7,470 | $445K |
| 2021 | 12,341 | $704K |
| 2022 | 18,870 | $1.09M |
| 2023 | 24,782 | $1.40M |
| 2024 | 26,689 | $1.35M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 92004 | 12,468 | 12,245 | $1.09M | |
| 92014 | 13,020 | 12,398 | $958K | |
| 99204 | 5,990 | 5,373 | $721K | |
| J0178 | Aflibercept injection | 677 | 596 | $565K |
| 99214 | 6,308 | 5,760 | $493K | |
| 92015 | 33,402 | 32,606 | $393K | |
| 66984 | 2,445 | 1,834 | $265K | |
| 99213 | 5,329 | 4,813 | $251K | |
| 92060 | 3,204 | 2,916 | $162K | |
| 67028 | 2,669 | 2,201 | $137K | |
| 92012 | 2,552 | 2,291 | $134K | |
| 92340 | 2,543 | 2,505 | $59K | |
| V2020 | Vision svcs frames purchases | 1,156 | 1,143 | $48K |
| V2103 | Spherocylindr 4.00d/12-2.00d | 1,148 | 990 | $45K |
| J9035 | Bevacizumab injection | 1,133 | 829 | $44K |
| 92134 | 2,425 | 2,221 | $43K | |
| 99232 | 592 | 291 | $32K | |
| J2777 | Inj, faricimab-svoa, 0.1mg | 24 | 24 | $24K |
| 92136 | 950 | 803 | $17K | |
| 99212 | 382 | 359 | $14K | |
| 67311 | 12 | 12 | $14K | |
| 92083 | 371 | 344 | $10K | |
| 92250 | 287 | 261 | $7K | |
| V2784 | Lens polycarb or equal | 568 | 272 | $5K |
| 99222 | 46 | 40 | $4K | |
| 92133 | 203 | 181 | $3K | |
| 92020 | 56 | 56 | $687.48 | |
| 76514 | 91 | 85 | $557.86 | |
| 83861 | 12 | 12 | $70.12 |